TY - JOUR
T1 - Medical and developmental risk factors of catatonia in children and adolescents
T2 - A prospective case-control study
AU - Consoli, Angèle
AU - Raffin, Marie
AU - Laurent, Claudine
AU - Bodeau, Nicolas
AU - Campion, Dominique
AU - Amoura, Zahir
AU - Sedel, Frederic
AU - An-Gourfinkel, Isabelle
AU - Bonnot, Olivier
AU - Cohen, David
N1 - Funding Information:
Funding/support: Grants from the French Ministry of Health (Programme Hospitalier de Recherche Clinique AOM 06-088) and the Fondation Wyeth pour la Santé de l'Enfant et de l'Adolescent funded this research. The funding agencies were not involved in the study design, collection, analysis and interpretation of data, writing of the paper, and/or the decision to submit for publication.
PY - 2012/5
Y1 - 2012/5
N2 - Context: Rare diseases have been associated with more and more genetic and non genetic causes and risk factors. But this has not been systematically assessed in catatonia, one of the psychiatric syndromes, that is most frequently associated with medical condition. Objective: We sought to assess the medical and developmental risk factors of catatonia in children and adolescents. Methods: From 1993 to 2009, 58 youths aged 10 to 18. years were prospectively admitted for catatonia and were followed up after discharge. A multidisciplinary approach assessed patients' medical condition and developmental history. A causality assessment scored medical risk (maximum score. =. 10; κ. =. 0.91). We compared the prevalence of catatonia in these patients to that of 80 inpatients with bipolar I disorder admitted from 1993 to 2003 who were also followed up. Results: We found that 13 (22.4%) patients had medical conditions and 18 (31%) had a history of developmental disorder in the catatonia group, whereas 1 (1.3%) and 17 (22.6%) patients had the same conditions in the bipolar group (p. <. 0.001; p. =. 0.17, respectively). Medical conditions associated with catatonia included auto-immune encephalitis (systemic lupus erythematosus [N. =. 3] and anti-NMDA-receptor encephalitis [N. =. 1]), seizures (N. =. 1), ciclosporin encephalitis (N. =. 1), post hypoglycaemic coma encephalitis (N. =. 1), and genetic or metabolic conditions (chorea [N. =. 2], 5HT cerebrospinal fluid deficit [N. =. 1], storage disease [N. =. 1], fatal familial insomnia [FFI; N. =. 1], and PRODH mutations [N. =. 1]). Six patients responded to a specific treatment approach related to their medical condition (e.g., plasma exchange in the case of auto-immune encephalitis). Conclusion: Catatonia in children and adolescents is associated with a high prevalence of medical conditions. This needs to be acknowledged as it may greatly delay the treatment of catatonia and the diagnosis of medically related catatonia. Tragically, this may deny patients treatment opportunities.
AB - Context: Rare diseases have been associated with more and more genetic and non genetic causes and risk factors. But this has not been systematically assessed in catatonia, one of the psychiatric syndromes, that is most frequently associated with medical condition. Objective: We sought to assess the medical and developmental risk factors of catatonia in children and adolescents. Methods: From 1993 to 2009, 58 youths aged 10 to 18. years were prospectively admitted for catatonia and were followed up after discharge. A multidisciplinary approach assessed patients' medical condition and developmental history. A causality assessment scored medical risk (maximum score. =. 10; κ. =. 0.91). We compared the prevalence of catatonia in these patients to that of 80 inpatients with bipolar I disorder admitted from 1993 to 2003 who were also followed up. Results: We found that 13 (22.4%) patients had medical conditions and 18 (31%) had a history of developmental disorder in the catatonia group, whereas 1 (1.3%) and 17 (22.6%) patients had the same conditions in the bipolar group (p. <. 0.001; p. =. 0.17, respectively). Medical conditions associated with catatonia included auto-immune encephalitis (systemic lupus erythematosus [N. =. 3] and anti-NMDA-receptor encephalitis [N. =. 1]), seizures (N. =. 1), ciclosporin encephalitis (N. =. 1), post hypoglycaemic coma encephalitis (N. =. 1), and genetic or metabolic conditions (chorea [N. =. 2], 5HT cerebrospinal fluid deficit [N. =. 1], storage disease [N. =. 1], fatal familial insomnia [FFI; N. =. 1], and PRODH mutations [N. =. 1]). Six patients responded to a specific treatment approach related to their medical condition (e.g., plasma exchange in the case of auto-immune encephalitis). Conclusion: Catatonia in children and adolescents is associated with a high prevalence of medical conditions. This needs to be acknowledged as it may greatly delay the treatment of catatonia and the diagnosis of medically related catatonia. Tragically, this may deny patients treatment opportunities.
KW - Adolescent
KW - Catatonia
KW - Child
KW - Developmental disorder
KW - Organic condition
UR - https://www.scopus.com/pages/publications/84860836040
U2 - 10.1016/j.schres.2012.02.012
DO - 10.1016/j.schres.2012.02.012
M3 - Article
C2 - 22401837
AN - SCOPUS:84860836040
SN - 0920-9964
VL - 137
SP - 151
EP - 158
JO - Schizophrenia Research
JF - Schizophrenia Research
IS - 1-3
ER -